References
- Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J. Oral. Maxillofac. Surg.65 , 369–376 (2007).
- Cartsos VM , SeamandurasA, KooS, ZavrasAI. Implications of bisphosphonate use in dentistry. Analecta Periodontologica20 , 1–15 (2009).
- Zavras AI . The impact of bisphosphonates on oral health: lessons from the past and opportunities for the future. Ann. NY Acad. Sci.1218 , 55–61 (2011).
- Palaska PK , CartsosV Zavras AI. Bisphosphonates and time to osteonecrosis development. Oncologist14 , 1154–1166 (2009).
- Nicoletti P , CartsosVM, PalaskaPK, ShenY, FloratosA, ZavrasAI. Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3. Oncologist17(2) , 279–287 (2012).
- Zavras AI , FunchD, MurelleL, DanielsonJ. Testing the feasibility of using an administrative medical claims database to study the pharmacogenetics of a rare adverse event. Presented at: The 2005 Meeting of the International Society for Pharmaco-Epidemiology. TN, USA, 21–24 August 2005 (Abstract 72).